The long-awaited solution for personalized medicine

QR Code

The long-awaited solution for personalized medicine

Saved in:

Bibliographic Details
Main Authors:	Olga Khorkova, Claes Wahlestedt
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Science
Subjects:	nucleic acid therapeutics lipid nanoparticles rare diseases personalized medicine regulatory compliance magistral production
Online Access:	https://www.frontiersin.org/articles/10.3389/fsci.2025.1629021/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Reimagining precision medicine for rare diseases—a clinical perspective on the promise of NANOSPRESSO
by: Daniel Petersheim, et al.
Published: (2025-06-01)

Aptamer-mediated delivery of therapeutic oligonucleotides in glioblastoma
by: Giorgia Castellani, et al.
Published: (2025-10-01)

Brewing nucleic acid therapies at the point of care
by: Horacio Cabral, et al.
Published: (2025-06-01)

Сationic liposomes as delivery systems for nucleic acids
by: A. A. Mikheev, et al.
Published: (2020-03-01)

NANOSPRESSO: toward personalized, locally produced nucleic acid nanomedicines
by: Mariona Estapé Senti, et al.
Published: (2025-06-01)

Biosample collection in a biobank to solve problems of personalized medicine
by: O. V. Kopylova, et al.
Published: (2025-01-01)

A multiscale physiologically based pharmacokinetic model to support mRNA-encoded BiTE therapy in cancer treatment
by: Giada Fiandaca, et al.
Published: (2025-09-01)

Nucleic acids /
by: Doonan, Shawn

Papuan epic /
by: Bushell, Keith
Published: (1936)

Application of therapeutic nucleic acids and RNA interference to create products for personalised medicine
by: I. P. Shilovskiy, et al.
Published: (2024-07-01)

Solid-phase synthesis of negatively charged oligomeric polyamide mimetics of nucleic acids
by: M. V. Shiryaeva, et al.
Published: (2011-04-01)

Application of Au10 gold nanoclusters to block the formation of DNA from non-canonical forms
by: Ten, Galina Nikolaevna, et al.
Published: (2025-06-01)

FROM PERSONALIZED TO PRECISION MEDICINE
by: K. V. Raskina, et al.
Published: (2017-03-01)

Elaboration of test for enantiomeric purity determination of chiral monomers of polyamide mimetics of nucleic acids
by: D. I. Prokhorov, et al.
Published: (2010-12-01)

THE EFFECT OF EXOGENOUS GLUCOSAMINE HYDROCHLORIDE AND CHONDROITIN SULFATE ON THE SYNTHESIS OF NUCLEIC ACIDS IN PERIODONTAL TISSUES DURING EXPERIMENTAL INFLAMMATION
by: N. I. BYKOVA, et al.
Published: (2017-06-01)

Personalized Critical Care Medicine (Review)
by: A. M. Golubev
Published: (2022-08-01)

Modern Bioinformatics Solutions Used for Genetic Data Analysis
by: Ya. A. Kibirev, et al.
Published: (2024-04-01)

Taming New Guinea /
by: Monckton, Charles Arthur Whitmore
Published: (1925)

Evolución de la formulación magistral en farmacias comunitarias de Bizkaia
by: Miren Edurne Hidalgo Pérez, et al.
Published: (2025-06-01)

ДЖЕНЕРИЧЕСКИЕ СТАТИНЫ В КЛИНИЧЕСКОЙ ПРАКТИКЕ: ДЕШЕВЫЕ ЗАМЕНИТЕЛИ ИЛИ ДОСТОЙНАЯ АЛЬТЕРНАТИВА БРЕНДАМ. АТОРВАСТАТИН
by: В. П. Михин, et al.
Published: (2012-04-01)

Cartilage‐Penetrating Framework Nucleic Acid Nanoparticles Ameliorate Osteoarthritis by Promoting Drug Delivery and Chondrocyte Uptake
by: Kui Huang, et al.
Published: (2025-07-01)

Linear DNA–Chitosan Nanoparticles: Formulation Challenges and Transfection Efficiency in Lung Cell Line
by: Chiara Migone, et al.
Published: (2025-06-01)

Multivalent Co-assembly of LL37-CpG nanoparticles: Enhanced immune response through activating multiple cell internalization pathways
by: Yushuang Wei, et al.
Published: (2025-08-01)

Proteins and nucleic acids in plant systematics
Published: (1983)

Efficient approach for producing pseudopeptide fragments – the key intermediates of the synthesis of polyamide nucleic acid mimics (PANAM)
by: A. V. Dezhenkov, et al.
Published: (2013-12-01)

Advancements in Pathogen Detection: Argonaute-Based Nucleic Acid Detection Technology
by: Meng Hong, et al.
Published: (2025-06-01)

Intranasal and Pulmonary Lipid Nanoparticles for Gene Delivery: Turning Challenges into Opportunities
by: Tayyar Y, et al.
Published: (2025-06-01)

The evolution of personalized medicine: literature review
by: I. S. Dolgopolov, et al.
Published: (2022-09-01)

GENOMIC MEDICINE AND PERSONALIZED MANAGEMENT OF SEPSIS
by: P. I. Mironov, et al.
Published: (2018-01-01)

Bronchial asthma in the era of personalized medicine
by: A. Kh. Ibisheva, et al.
Published: (2025-01-01)

Clinical and pharmacological technologies of personalized medicine: what now and what will happen?
by: D. A. Sychev
Published: (2019-12-01)

Is the concept of type D personality a component of personalized medicine or a prognostic factor in the treatment of cardiovascular diseases?
by: A. N. Sumin, et al.
Published: (2020-09-01)

Therapeutic education and treatment compliance in hypertensive patients
by: S. E. Ushakova, et al.
Published: (2005-02-01)

Bisoprolol and magnesium medications in arterial hypertension treatment
by: A. M. Shilov, et al.
Published: (2005-02-01)

THERAPEUTIC EXERCISE FOR PATIENTS WITH ANKYLOSING SPONDYLITIS: RECOMMENDATIONS AND REALITY
by: T. V. Dubinina, et al.
Published: (2014-06-01)

Compounding pharmacy regulations: experience of the Latvian pharmaceutical market
by: D. D. Mamedov, et al.
Published: (2024-05-01)

Personalized Medicine in the Treatment of Atrial Fibrillation: Myth or Reality?
by: V. I. Podzolkov, et al.
Published: (2019-03-01)

CHANGING THE PROPERTIES OF THE STEEL 10G2BF AFTER HOT ROLLING
by: A. B. Steblov, et al.
Published: (2016-08-01)

Social individual circumstances of the personalized medicine in prevention of the family of fetus anomalies (review of international experience)
by: A. S. Kiselev
Published: (2014-03-01)

Review of the Certification Procedure for Qualified Persons of Manufacturers of Medicines for Human Use in Russia
by: Zh. I. Aladysheva, et al.
Published: (2023-09-01)